BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
PPARA
,
G-protein-coupled receptor binding
,
Pseudomonas infection
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Peptide chain release factor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Ileum mucosa
Jejunum
Colon
Myeloid cells of peripheral blood
Spleen
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vesicular stomatitis Indiana virus disease
Pyloric ulcer
Sarcoidosis
Staphylococcal infectious disease
Streptococcal infectious disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
gamma-Tocopherol
Ions
alpha-Tocopherol
betulin
loxoprofen
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
FGFR1
Mir10a
PRPF4B
MSTN
SPRY4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
L1000 CMAP Prostate cancer VCaP cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Peptide chain release factor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma
Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
Tolerability and Modulatory Action of the Butyrate Releaser N-(1-carbamoyl-2-phenyl-ethyl) Butyramid…
Vaccine Treatment of Kidney Cancer
Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ